I-Mab Announces Voluntary Lock-ups by Key Shareholders and Senior Management for Long-Term Commitment
/PRNewswire/ -- I-Mab (the "Company") (Nasdaq: IMAB), a clinical-stage biopharmaceutical company committed to the discovery, development, and commercialization...
Source: prnewswire.com